RNAV8 Bio
PrivateLast Round
Seed
Mar 17, 2025
Total Funding Raised
$1.01M
Company Overview
RNAV8 Bio is a biotechnology company that provides an AI-enabled mRNA engineering platform to optimize coding and non-coding sequences for improved therapeutic outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNAV8 Bio Comparables
Compare RNAV8 Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Raina Biosciences | 89% | |
| Inceptive | 76% | |
| Atomic AI | 66% |
RNAV8 Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 17, 2025 |
RNAV8 Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Service Provider Capital | Seed |
| Calm Ventures | Seed |
| BioBrit | Seed |
| Portal Innovations | Seed |
RNAV8 Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RNAV8 Bio's valuation, stock price, and market status.
Is RNAV8 Bio a public or private company?
RNAV8 Bio is a private company.
What is the current stock price of RNAV8 Bio?
RNAV8 Bio is a private company with no public stock price. No recent secondary market data is available.
How much is RNAV8 Bio worth (valuation)?
Valuation information for RNAV8 Bio is not publicly available.
Can I buy RNAV8 Bio stock?
RNAV8 Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RNAV8 Bio's last funding round?
RNAV8 Bio's most recent funding round was Seed on March 17, 2025.
Who are the main investors in RNAV8 Bio?
Key investors in RNAV8 Bio include Service Provider Capital, Calm Ventures, BioBrit, Portal Innovations.
Will RNAV8 Bio IPO soon?
No public IPO plans have been announced for RNAV8 Bio.
How can I track RNAV8 Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RNAV8 Bio's secondary market activity and sign up for updates.